Novel inhibitors

You can also try the following methods, and our professionals will serve you Customized Consultation

Cat. No.	Product Name	Field of Application
DCC3594	ncx-2057	Novel NO-donor, suppressing inflammatory and nociceptive responses More description
DCC3593	Nctu-alan-2026	Novel blocker of the interaction between FGF1 and FGFRD2 to inhibit cell proliferation, showing potent antiproliferent with less cytotoxicity. More description
DCC3592	Ncs-8591	Beclin 1 mimetic, selectively binding to Bcl-xL and inducing autophagy, showing potent cytotoxicity in PC-3, PC-3a and DU145 prostate cancer cells More description
DCC3591	Ncs-382	Analogue of γ-hydroxybutyric acid (GHB), acting as a substrate for both the monocarboxylate transporter subtype 1 (MCT1) and subtype 4 (MCT4) More description
DCC3590	Ncrw0005-f05	Novel GPR139 receptor agonist More description
DCC3589	Nco-04	Novel SIRT1 inhibitor, inducing cell death in adult T-cell leukaemia cells More description
DCC3588	Ncgc2327	Novel potent inhibitor of IRAK1/4 and FLT3 More description
DCC3587	Ncgc00262654	Novel AMA1-RON2 Inhibitor More description
DCC3586	Ncgc00249987	Novel allosteric Eya2 phosphatase inhibitor, specifically targeting migration, invadopodia formation, and invasion of lung cancer cells More description
DCC3585	ncgc00242595	TSHR neutral antagonist, inhibiting stimulated signaling but not basal signaling More description
DCC3583	Ncgc00120943	Novel Agonist for Human Resolvin D1 Receptor DRV1 with Pro-Resolving Functions More description
DCC3582	Ncgc00117362	Novel inhibitor of ovarian cancer metastasis, adhesion, invasion and proliferation More description
DCC3581	Ncdm-32	Potent pan KDM Inhibitor, inhibiting KDM2A, KDM7A, KDM7B, KDM4A, KDM4C, and KDM5A More description
DCC3580	Ncb0970	Less active trans-isomer of NCB-0846, acting as the negative control for NCB-0846, showing 13-fold weaker TNIK enzyme-inhibitory activity More description
DCC3579	Ncats-sm1441	First-in-class, potent, and selective Lactate dehydrogenase inhibitor More description
DCC3578	Ncats-sm1440	First-in-class, potent, and selective Lactate dehydrogenase inhibitor More description
DCC3577	Nc2213	Novel inhibitor of methionine aminopeptidase 2 (MetAP2) More description
DCC3576	nc00094221	M. tuberculosis Dihydrofolate Reductase Inhibitor More description
DCC3575	Nbti-5463	Novel bacterial type II topoisomerase inhibitor with activity against gram-negative bacteria and in vivo efficacy More description
DCC3574	Nboh-2c-cn Hydrochloride	Potent and selective 5-HT2A receptor agonist More description
DCC3573	N-bn-thaz Fumarate	Potent agonist of the human 5-HT2A and 5-HT2C receptors More description
DCC3572	Nbd-14136	Novel CD4-mimetic HIV-1 entry inhibitor More description
DCC3571	Nbd-10007	Novel HIV-1 entry inhibitor More description
DCC3570	Nbd-09027	Novel HIV-1 entry inhibitor More description
DCC3569	Nb-caged Tyrosine Hydrochloride	L-Tyrosine caged with photosensitive ortho-nitrobenzyl side chain More description
DCC3568	Nb-360	Biological Active Reagents More description
DCC3567	Naxifylline	Potent and selective A1 adenosine receptor antagonist More description
DCC3566	Naveglitazar	Dual peroxisome proliferator-activated receptor gamma and alpha (PPARgamma and PPARalpha) agonist More description
DCC3565	Navarixin	Novel CXC chemokine receptor 2 (CXCR2) antagonist More description
DCC3564	Nav1.7 Blocker-801	Potent NaV1.7 blocker, being 5-10 fold more potent than NaV 1.2 and NaV 1.6 More description

Novel inhibitors

Customized Consultation X

Your information is safe with us. * Required Fields.